Next Quarterly Earnings
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
BioGaia AB, headquartered in Sweden, is a leading biotechnology company specializing in the research, development, and distribution of probiotic products. The company offers scientifically proven dietary supplements for gut health, immune defense, and general well-being. BioGaia develops solutions based on specific lactobacilli strains, marketing them globally to enhance human health.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
BioGaia is scheduled to report its next quarterly earnings on 10/22/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
BioGaia last reported quarterly earnings on 7/17/2026 (Q2 2026). Earnings per share (EPS) came in at 1.01 SEK.
Across its last 5 earnings reports, BioGaia stock moved by ±4.7% on average the following day. The largest reaction was +8.7% on 05/07/2026; 2 of 5 reactions were positive.
BioGaia has beaten analyst EPS estimates in 2 of its last 5 evaluated quarters (beat rate: 40%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 5 report dates (close to close).
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.